// App-Quantinova.ai

: Mediastinal Mass, Triglycerides Level Above 1000mg/Dl and Intensive Dexamethasone and Asparaginase Treatment Are Risk Factors for Cerebral Sinus Venous Thrombosis in Children Treated for Acute Lymphoblastic Leukemia at the Children's Cancer Center of Lebanon

Researchers

Presenter

  • Habib El-Khoury

Principal Investigators

  • Khaled M Ghanem

  • Yaacoub Mubarak

  • Nidale Tarek

  • Hassan El Solh

  • Anthony K.C. Chan

  • Carole Aridi

  • Miguel R. Abboud

  • Raya Saab

  • Samar A. Muwakkit

Medical Centers

  • Faculty of Arts and Sciences, American University of Beirut, Beirut, Lebanon

  • Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon

  • American University of Beirut (AUB), Beirut, Lebanon

  • McMaster University, Hamilton, ON, Canada

Locations

  • Lebanon

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Acute lymphoblastic leukemia

  • Venous thrombosis

  • Mediastinal mass

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Asparaginase

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved